Saturday, March 26, 2016
New Vet dairy cow drug Imrestor to stop mastitus
Health Canada, Voice file photo
ealth Canada and the United States Food and Drug Administration's Center for Veterinary Medicine today announced a simultaneous approval of the veterinary drug Imrestor. Access to this drug will provide Canadian dairy farmers with an innovative product to reduce the incidence of clinical mastitis, a significant infectious disease that affects approximately 15% of dairy cattle.
"This drug's approval will provide Canadian dairy farmers with access to an innovative product to treat a common but serious condition, and likely lead to fewer animals needing treatment from antimicrobial drugs. Thanks to our government's collaboration with our American counterparts, the approval was able to be expedited and will help to improve the health and well-being of Canadian cattle," said The Honourable Jane Philpott, Minister of Health, Friday.
At the time of calving, dairy cows often have a lowered immune system, which can lead to infections. Imrestor is an innovative drug that restores immune response and reduces the incidence of clinical mastitis—reducing reliance on other drugs, including antimicrobials, to treat mastitis infections.
This is the fourth drug to be approved under the Regulatory Cooperation Council (RCC), but it is the first drug to be approved for use in food-producing animals.
© 2009-2016 The Valley Voice News | All Rights Reserved